Noticias de ARWR_US

Noticias del mercado

Últimas noticias sobre ARWR_US — 135 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: ARWR_US ✕ 135 resultados
21/04/2026 ARWR_US — Sahm
Arrowhead Pharmaceuticals To Rally Over 44%? Here Are 10 Top Analyst Forecasts For Tuesday
21/04/2026 ARWR_US — Benzinga
Arrowhead Pharmaceuticals To Rally Over 44%? Here Are 10 Top Analyst Forecasts For Tuesday
21/04/2026 ARWR_US — Seeking Alpha
Arrowhead stock upgraded at Morgan Stanley (ARWR:NASDAQ)
21/04/2026 ARWR_US — MEXC
Arrowhead Pharmaceuticals (ARWR) Stock Surges 481% — Wall Street Eyes Further Gains
20/04/2026 ARWR_US — The National Law Review ES ← EN
Arrowhead Pharmaceuticals transmitirá por web los resultados del segundo trimestre del año fiscal 2026

Arrowhead Pharmaceuticals to Webcast Fiscal 2026 Second Quarter Results

20/04/2026 ARWR_US — PharmiWeb.com
Arrowhead Pharmaceuticals to Webcast Fiscal 2026 Second Quarter Results
20/04/2026 ARWR_US — MSN ES ← EN
El precio objetivo de Arrowhead Pharmaceuticals (ARWR) aumentó un 23,01 % hasta 77,60

Arrowhead Pharmaceuticals (ARWR) price target increased by 23.01% to 77.60

20/04/2026 ARWR_US — ChartMill
Arrowhead Pharmaceuticals to Webcast Fiscal 2026 Second Quarter Results
20/04/2026 ARWR_US — Business Wire
Arrowhead Pharmaceuticals to Webcast Fiscal 2026 Second Quarter Results
20/04/2026 ARWR_US — Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals to Webcast Fiscal 2026 Second Quarter Results
16/04/2026 ARWR_US — MarketBeat
Arrowhead Pharmaceuticals (NASDAQ:ARWR) Shares Cross Above 200-Day Moving Average - Here's Why
14/04/2026 ARWR_US — Stock Titan
S&P reshuffle adds ADT to SmallCap 600 as Ciena moves into the S&P 500
13/04/2026 ARWR_US — MSN ES ← EN
ARO-ALK7 de Arrowhead Pharmaceuticals, Inc. (ARWR) ingresa al estudio de fase 1/2a
11/04/2026 ARWR_US — ChartMill
Arrowhead Pharmaceuticals (NASDAQ:ARWR) Emerges as a Growth Stock with a Constructive Technical Setup
07/04/2026 ARWR_US — MarketBeat
Aberdeen Group plc Sells 234,498 Shares of Arrowhead Pharmaceuticals, Inc. $ARWR
06/04/2026 ARWR_US — MarketBeat
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Given Consensus Recommendation of "Moderate Buy" by Brokerages
03/04/2026 ARWR_US — MarketBeat
Tema Etfs LLC Reduces Holdings in Arrowhead Pharmaceuticals, Inc. $ARWR
28/03/2026 ARWR_US — PharmiWeb.com ES ← EN
Arrowhead Pharmaceuticals presenta nuevos datos de eficacia y seguridad a largo plazo para plozasiran en todo el mundo
28/03/2026 ARWR_US — Yahoo Finance
Arrowhead Pharmaceuticals Presents New Long-Term Efficacy and Safety Data for Plozasiran Across a Spectrum of Hypertriglyceridemia at the American College of Cardiology’s 75th Annual Scientific Session and Expo
28/03/2026 ARWR_US — Business Wire
Arrowhead Pharmaceuticals Presents New Long-Term Efficacy and Safety Data for Plozasiran Across a Spectrum of Hypertriglyceridemia at the American College of Cardiology’s 75th Annual Scientific Session and Expo

Página 6 de 7

keyboard_arrow_up